Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Analysis
  • Published:

Is corporate and analyst hype unethical?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. The Wall Street Journal, 5/20/94, p. R16.

  2. SciClone Pharmaceuticals, Form 10-K, 3/30/94, pp. 14–15.

  3. Business Week, 6/22/92, p. 108.

  4. Business Week, 6/21/93, p. 144.

  5. Business Week, 7/12/93, p. 136.

  6. The New York Times, 4/29/94, p. C3.

  7. The Los Angeles Times, 5/16/94, pp. D1,D6.

  8. Hepatology, 1991, 14: 567–569.

  9. Sturza's Medical Investment Letter, 6/1/93, pp. 1,4,6.

  10. The Wall Street Journal, 3/19/93, p.C1.

  11. SciClone Pharmaceuticals, CDA/ Spectrum 13F Institutional Ownership as of 12/31/93, Compact Disclosure D/SEC, May 1994, CD-ROM.

  12. Medical Technology Stock Letter, 2/11/93, pp. 1, 3–4.

  13. Money, June 1994, p. 69.

  14. Bio/Technology, June 1993, 11: 664–665.

  15. SciClone Pharmaceuticals, Form 10–Q, 5/12/94, p. 12.

  16. Journal of Business Ethics, February 1994, 13: 111–123.

  17. The New York Times, 5/25/94, p. C16.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothenberg, L. Is corporate and analyst hype unethical?. Nat Biotechnol 12, 763–765 (1994). https://doi.org/10.1038/nbt0894-763

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0894-763

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing